Biktarvy, formally known as bictegravir, represents a effective single-tablet therapy for treating HIV infection. This drug combines three crucial antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the HIV's ability to copy within the body, remarkably decreasing the viral burden. For many individuals,